跳至主要内容
临床试验/IRCT20220302054170N1
IRCT20220302054170N1尚未招募2 期

investigating the effect of Viola odorata L. tablet on breast cancer-related fatigue: Pilot study

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
Female

入选标准

  • Women aged 18 to 70 years old
  • Suffering from breast cancer
  • During radiotherapy
  • Hemoglobin at least 8 g / dl
  • Hematocrit at least 30%
  • SGOT level less than 3 times the upper limit of normal
  • Bilirubin less than 2mg / dl
  • Creatinine less than 2mg / dl

排除标准

  • Heart disease with unstable conditions
  • Debilitating lung disease
  • History of asthma
  • History of allergies to Viola or any of the excipients in tablets
  • Uncontrolled pain
  • Severe infection
  • Serious accompanying disease

研究者

相似试验